EffECT OF SHWETA CHANDANADI LEPA AND KINSUKADI TAILAM IN SKIN ALLERGY DUE TO COSMETIC PRODUCTE

Phase 2

Not yet recruiting

Brief Summary: The study is a Randomized comparative clinical and open-label study to compare the effect of the *Shweta chandanadi lep* and s *Kinshukadi Tailam* in cosmetic induce skin allergy.

**Grouping for Clinical Study****:** 90 clinically diagnosed and registered patient of *Cosmetic induced skin allergy will* be divided randomly into two groups. Each group will have 45 patients.

                        **GROUP A****:** 45 clinically diagnosed and registered patient of skin*allergy* will be treated by local application of *Shweta chandanadi lepa and internal use of* *Manjisthadi kwath*

Duration â€“ 2 month

Dose â€“    1.   *Lepa* once daily for 2 month with *honey*

2*.*40 ml *Kwath* twice daily

**GROUP B**: 45 clinically diagnosed and registered patient of *skin allergy* will be treated by local application of *Kinshukadi Tailam and internal use of* *Manjisthadi kwath*

Duration â€“      2   month

Dose â€“ 1.      40 ml/ week oil for external application

2.       40 ml *Kwath* twice daily

**FOLLOW UP**

Follow up of the patients will be taken at every 15 days interval for 60 days i.e. 1st day, 15 days, 30 days, 45 days and 60 days of study.

Recruitment & Eligibility

Inclusion Criteria

1.All patients having complaint skin allergy due to use of any cosmetics and of clinical features like redness itching, urticaria, rashes will be selected for this clinical trial.
2.Patients of age group 20-70 years of either gender visiting the OPD and willing to provide written, informed consent will be selected to the study on basis of specially prepared Performa including relevant parameters.
3.Patients will be selected randomly, irrespective of gender, economical, educational and marital status.
4.Patient ready to give written informed consent.

Exclusion Criteria

âž¢Patients not ready to give an informed consent.
âž¢Patients who have been diagnosed to have local disease like burn, psoriasis leucoderma, leprosy, herpes, measles.
âž¢Patients suffering from any kind of Malignancy, Diabetes, Cardiac disorder, HIV etc.
âž¢Patients who are on steroids or there is history of prolonged steroid use or chemo-therapeutic agents.

Primary Outcome Measures

Name	Time	Method
Skin Allergy	3 Month ,15 day

Secondary Outcome Measures

Name	Time	Method
Contact dermatitis	6 Month

Locations (1): National Institute of Ayurveda
🇮🇳
Jaipur, RAJASTHAN, India
National Institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Monika Sharma
Principal investigator
9587408126
sharmania64@gmail.com